Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Target Identification in Anti-tuberculosis Drug Discovery

Version 1 : Received: 31 May 2023 / Approved: 2 June 2023 / Online: 2 June 2023 (07:39:37 CEST)

A peer-reviewed article of this Preprint also exists.

Capela, R.; Félix, R.; Clariano, M.; Nunes, D.; Perry, M.J.; Lopes, F. Target Identification in Anti-Tuberculosis Drug Discovery. Int. J. Mol. Sci. 2023, 24, 10482. Capela, R.; Félix, R.; Clariano, M.; Nunes, D.; Perry, M.J.; Lopes, F. Target Identification in Anti-Tuberculosis Drug Discovery. Int. J. Mol. Sci. 2023, 24, 10482.

Abstract

Mycobacterium tuberculosis (Mtb) is the etiological agent of tuberculosis (TB), a disease that alt-hough preventable and curable, remains a global epidemic due to the emergence of resistance and a latent form responsible for a long period of treatment. Drug discovery in TB is a challenging task due to the heterogeneity of the disease, the emergence of resistance and an uncomplete knowledge of the pathophysiology of the disease. The limited permeability of the cell wall and the presence of multiple efflux pumps remain a major barrier to achieve effective intracellular drug accumulation. While the complete genome sequence of Mtb has been determined and several potential protein targets have been validated, the lack of adequate models for in vitro and in vivo studies is a limit-ing factor in TB drug discovery programs. In current therapeutic regimens, less than 0.5% of bac-terial proteins are targeted being the biosynthesis of the cell wall and the energetic metabolism two of the most important processes exploited for TB chemotherapeutics. This review provides an overview on the current challenges in TB drug discovery and emerging Mtb druggable proteins, and how chemical probes for protein profiling enabled the identification of new targets and bi-omarkers, paving the way to disruptive therapeutic regimens and diagnostic tools.

Keywords

Mycobacterium tuberculosis; target identification; activity-based probes; affinity-based probes

Subject

Chemistry and Materials Science, Medicinal Chemistry

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.